The price of this share is at 8,04$, In this post we are going to talk about the listed company Adverum Biotechnologies Inc, its leaders are Angela Thedinga (Chief Technology Officer), Brigit Riley (Chief Scientific Officer), Jon Williams (Vice President-Clinical Affairs), Julie Clark (Chief Medical Officer), Laurent Fischer (President, Chief Executive Officer & Director), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
Today this action begins with yesterday's closing price, desconocido$.
The current range on the same day is from 7,86$ - 8,38$, with a percentage difference of 8,12$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
